Microarray analysis of gene expression changes in the brains of NR2B-induced memory-enhanced mice

Neuroscience

Volumn 197, Issue , 2011, Pages 121-131

  Li, C ^a   Dong, S ^a   Wang, H ^a   Hu, Y ^a  

^a B326 Science Building   (China)

Author keywords

Gene expression profile; Homer 1c; Microarray; NR2B transgenic mice; RyR

Indexed keywords

CALCIUM BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTIDINE RICH CALCIUM BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROTEIN C FOS; PROTEIN HOMER 1C; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR 3; TRIADIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CALCIUM SIGNALING; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; ENGR2 GENE; ENGR4 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HORMONE ACTION; LEARNING; MEMORY; MICROARRAY ANALYSIS; MOUSE; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; BRAIN; GENE EXPRESSION PROFILING; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; MEMORY; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 82855161311     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.08.031     Document Type: Article

References (74)

1. Adasme T., Haeger P., Paula-Lima A.C., Espinoza I., Casas-Alarcón M.M., Carrasco M.A., Hidalgo C. Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation. Proc Natl Acad Sci U S A 2011, 108:3029-3034.
2. Amparan D., Avram D., Thomas C.G., Lindahl M.G., Yang J., Bajaj G., Ishmael J.E. Direct interaction of myosin regulatory light chain with the NMDA receptor. J Neurochem 2005, 92:349-361.
3. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., Sherlock G. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 2000, 25:25-29.
4. Beneyto M., Kristiansen L.V., Oni-Orisan A., McCullumsmith R.E., Meador-Woodruff J.H. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 2007, 32:1888-1902.
5. Billuart P., Winter C.G., Maresh A., Zhao X., Luo L. Regulating axon branch stability: the role of p190 RhoGAP in repressing a retraction signaling pathway. Cell 2001, 107:195-207.
6. Bruno AM, Huang JY, Bennett DA, Marr RA, Hastings ML, Stutzmann GE (in press) Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging, in press.
7. Cheong E., Kim C., Choi B.J., Sun M., Shin H.S. Thalamic ryanodine receptors are involved in controlling the tonic firing of thalamocortical neurons and inflammatory pain signal processing. J Neurosci 2011, 31:1213-1218.
8. Cole G.M., Frautschy S.A. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's disease. Exp Gerontol 2007, 42:10-21.
9. Collingridge G.L., Bliss T.V. Memories of NMDA receptors and LTP. Trends Neurosci 1995, 18:54-56.
10. Dik M.G., Pluijm S.M., Jonker C., Deeg D.J., Lomecky M.Z., Lips P. Insulin-like growth factor I (IGF-I) and cognitive decline in older persons. Neurobiol Aging 2003, 24:573-581.
11. Dong S., Li C., Wu P., Tsien J.Z., Hu Y. Environment enrichment rescues the neurodegenerative phenotypes in presenilins-deficient mice. Eur J Neurosci 2007, 26:101-112.
12. Draghici S., Khatri P., Tarca A.L., Amin K., Done A., Voichita C., Georgescu C., Romero R. A systems biology approach for pathway level analysis. Genome Res 2007, 17:1537-1545.
13. Duncan R.S., Hwang S.Y., Koulen P. Effects of Vesl/Homer proteins on intracellular signaling. Exp Biol Med (Maywood) 2005, 230:527-535.
14. Fan G.C., Gregory K.N., Zhao W., Park W.J., Kranias E.G. Regulation of myocardial function by histidine-rich, calcium-binding protein. Am J Physiol Heart Circ Physiol 2004, 287:H1705-H1711.
15. Feng W., Tu J., Yang T., Vernon P.S., Allen P.D., Worley P.F., Pessah I.N. Homer regulates gain of ryanodine receptor type 1 channel complex. J Biol Chem 2002, 277:44722-44730.
16. Fernandes H.B., Raymond L.A. NMDA Receptors and Huntington's disease. Biology of the NMDA receptor (Frontiers in Neuroscience) 2009, 17-40. CRC Press, Boca Raton, FL. A.M. VanDongen (Ed.).
17. Galeotti N., Vivoli E., Bartolini A., Ghelardini C. A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. J Neurochem 2008, 106:2385-2394.
18. Ghanizadeh A. Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment. Neurochem Res 2011, 36:922-923.
19. Gilmour G, Dix S, Fellini L, Gastambide F, Plath N, Steckler T, Talpos J, Tricklebank M (in press) NMDA receptors, cognition and schizophrenia-testing the validity of the NMDA receptor hypofunction hypothesis. Neuropharmacology, in press.
20. Goussakov I., Miller M.B., Stutzmann G.E. NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice. J Neurosci 2010, 30:12128-12137.
21. Hokyo A., Kanazawa T., Uenishi H., Tsutsumi A., Kawashige S., Kikuyama H., Glatt S.J., Koh J., Nishimoto Y., Matsumura H., Motomura N., Yoneda H. Habituation in prepulse inhibition is affected by a polymorphism on the NMDA receptor 2B subunit gene (GRIN2B). Psychiatr Genet 2010, 20:191-198.
22. Husi H., Ward M.A., Choudhary J.S., Blackstock W.P., Grant S.G. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci 2000, 3:661-669.
23. Hwang S.Y., Wei J., Westhoff J.H., Duncan R.S., Ozawa F., Volpe P., Inokuchi K., Koulen P. Differential functional interaction of two Vesl/Homer protein isoforms with ryanodine receptor type 1: a novel mechanism for control of intracellular calcium signaling. Cell Calcium 2003, 34:177-184.
24. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 2001, 294:1030-1038.
25. Kanehisa M., Goto S., Kawashima S., Okuno Y., Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004, 32:D277-D280.
26. Karlsgodt K.H., Robleto K., Trantham-Davidson H., Jairl C., Cannon T.D., Lavin A., Jentsch J.D. Reduced dysbindin expression mediates N-methyl-d-aspartate receptor hypofunction and impaired working memory performance. Biol Psychiatry 2011, 69:28-34.
27. Korkotian E., Segal M. Release of calcium from stores alters the morphology of dendritic spines in cultured hippocampal neurons. Proc Natl Acad Sci U S A 1999, 96:12068-12072.
28. Kristiansen L.V., Patel S.A., Haroutunian V., Meador-Woodruff J.H. Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia. Synapse (New York, NY) 2010, 64:495-502.
29. Li C., Niu W., Jiang C.H., Hu Y. Effects of enriched environment on gene expression and signal pathways in cortex of hippocampal CA1 specific NMDAR1 knockout mice. Brain Res Bull 2007, 71:568-577.
30. Lonze B.E., Ginty D.D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002, 35:605-623.
31. Ludwig A., Uvarov P., Soni S., Thomas-Crusells J., Airaksinen M.S., Rivera C. Early growth response 4 mediates BDNF induction of potassium chloride cotransporter 2 transcription. J Neurosci 2011, 31:644-649.
32. Ma Y.Y., Cepeda C., Cui C.L. The role of striatal NMDA receptors in drug addiction. Int Rev Neurobiol 2009, 89:131-146.
33. Machado-Vieira R., Yuan P., Brutsche N., Diaz Granados N., Luckenbaugh D., Manji H.K., Zarate C.A. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-d-aspartate antagonist. J Clin Psychiatry 2009, 70:1662-1666.
34. Maeng S., Zarate C.A. The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 2007, 9:467-474.
35. Matsuo N., Tanda K., Nakanishi K., Yamasaki N., Toyama K., Takao K., Takeshima H., Miyakawa T. Comprehensive behavioral phenotyping of ryanodine receptor type 3 (RyR3) knockout mice: decreased social contact duration in two social interaction tests. Front Behav Neurosci 2009, 3:3.
36. Melik E., Babar E., Ozen E., Ozgunen T. Hypofunction of the dorsal hippocampal NMDA receptors impairs retrieval of memory to partially presented foreground context in a single-trial fear conditioning in rats. Eur Neuropsychopharmacol 2006, 16:241-247.
37. Meng J., Meng Y., Hanna A., Janus C., Jia Z. Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3. J Neurosci 2005, 25:6641-6650.
38. Mony L., Kew J.N., Gunthorpe M.J., Paoletti P. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br J Pharmacol 2009, 157:1301-1317.
39. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12:529-540.
40. Moosavi M., Naghdi N., Maghsoudi N., Zahedi Asl S. Insulin protects against stress-induced impairments in water maze performance. Behav Brain Res 2007, 176:230-236.
41. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992, 258:597-603.
42. Neeb L., Meents J., Reuter U. 5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?. Neurotherapeutics 2010, 7:176-182.
43. Nguyen T.V., Galvan V., Huang W., Banwait S., Tang H., Zhang J., Bredesen D.E. Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. J Neurochem 2008, 104:1065-1080.
44. Okereke O., Kang J.H., Ma J., Hankinson S.E., Pollak M.N., Grodstein F. Plasma IGF-I levels and cognitive performance in older women. Neurobiol Aging 2007, 28:135-142.
45. Poirier R., Cheval H., Mailhes C., Charnay P., Davis S., Laroche S. Paradoxical role of an egr transcription factor family member, egr2/krox20, in learning and memory. Front Behav Neurosci 2007, 1:6.
46. Pouliquin P., Dulhunty A.F. Homer and the ryanodine receptor. Eur Biophys J 2009, 39:91-102.
47. Rajeevan M.S., Ranamukhaarachchi D.G., Vernon S.D., Unger E.R. Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 2001, 25:443-451.
48. Rampon C., Tang Y.P., Goodhouse J., Shimizu E., Kyin M., Tsien J.Z. Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice. Nat Neurosci 2000, 3:238-244.
49. Rossi D., Sorrentino V. Molecular genetics of ryanodine receptors Ca2+-release channels. Cell Calcium 2002, 32:307-319.
50. Scarr E., Pavey G., Copolov D., Dean B. Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjects. Schizophr Res 2004, 71:383-392.
51. Schlitt T., Palin K., Rung J., Dietmann S., Lappe M., Ukkonen E., Brazma A. From gene networks to gene function. Genome Res 2003, 13:2568-2576.
52. Shakiryanova D., Klose M.K., Zhou Y., Gu T., Deitcher D.L., Atwood H.L., Hewes R.S., Levitan E.S. Presynaptic ryanodine receptor-activated calmodulin kinase II increases vesicle mobility and potentiates neuropeptide release. J Neurosci 2007, 27:7799-7806.
53. Sheng M., Cummings J., Roldan L.A., Jan Y.N., Jan L.Y. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 1994, 368:144-147.
54. Shimizu E., Tang Y.P., Rampon C., Tsien J.Z. NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation. Science 2000, 290:1170-1174.
55. Shimuta M., Yoshikawa M., Fukaya M., Watanabe M., Takeshima H., Manabe T. Postsynaptic modulation of AMPA receptor-mediated synaptic responses and LTP by the type 3 ryanodine receptor. Mol Cell Neurosci 2001, 17:921-930.
56. Skolnick P., Popik P., Trullas R. Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci 2009, 30:563-569.
57. Swanberg S.E., Nagarajan R.P., Peddada S., Yasui D.H., LaSalle J.M. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism. Hum Mol Genet 2009, 18:525-534.
58. Tan P.H., Yang L.C., Shih H.C., Lan K.C., Cheng J.T. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther 2005, 12:59-66.
59. Tang Y.P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhuo M., Liu G., Tsien J.Z. Genetic enhancement of learning and memory in mice. Nature 1999, 401:63-69.
60. Tsien J.Z. Linking Hebb's coincidence-detection to memory formation. Curr Opin Neurobiol 2000, 10:266-273.
61. Tsien J.Z., Huerta P.T., Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 1996, 87:1327-1338.
62. Tu J.C., Xiao B., Naisbitt S., Yuan J.P., Petralia R.S., Brakeman P., Doan A., Aakalu V.K., Lanahan A.A., Sheng M., Worley P.F. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 1999, 23:583-592.
63. Unni V.K., Zakharenko S.S., Zablow L., DeCostanzo A.J., Siegelbaum S.A. Calcium release from presynaptic ryanodine-sensitive stores is required for long-term depression at hippocampal CA3-CA3 pyramidal neuron synapses. J Neurosci 2004, 24:9612-9622.
64. Wang D., Cui Z., Zeng Q., Kuang H., Wang L.P., Tsien J.Z., Cao X. Genetic enhancement of memory and long-term potentiation but not CA1 long-term depression in NR2B transgenic rats. PLoS One 2009, 4:e7486.
65. Ward C.W., Feng W., Tu J., Pessah I.N., Worley P.K., Schneider M.F. Homer protein increases activation of Ca2+ sparks in permeabilized skeletal muscle. J Biol Chem 2004, 279:5781-5787.
66. Wei F., Wang G.D., Kerchner G.A., Kim S.J., Xu H.M., Chen Z.F., Zhuo M. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci 2001, 4:164-169.
67. Westhoff J.H., Hwang S.Y., Duncan R.S., Ozawa F., Volpe P., Inokuchi K., Koulen P. Vesl/Homer proteins regulate ryanodine receptor type 2 function and intracellular calcium signaling. Cell Calcium 2003, 34:261-269.
68. Williams J., Dragunow M., Lawlor P., Mason S., Abraham W.C., Leah J., Bravo R., Demmer J., Tate W. Krox20 may play a key role in the stabilization of long-term potentiation. Brain Res Mol Brain Res 1995, 28:87-93.
69. Worley P.F., Zeng W., Huang G., Kim J.Y., Shin D.M., Kim M.S., Yuan J.P., Kiselyov K., Muallem S. Homer proteins in Ca2+ signaling by excitable and non-excitable cells. Cell Calcium 2007, 42:363-371.
70. Yi M., Horton J.D., Cohen J.C., Hobbs H.H., Stephens R.M. WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinform 2006, 7:30.
71. Zhang C., Wu B., Beglopoulos V., Wines-Samuelson M., Zhang D., Dragatsis I., Südhof T.C., Shen J. Presenilins are essential for regulating neurotransmitter release. Nature 2009, 460:632-636.
72. Zhang H., Sun S., Herreman A., De Strooper B., Bezprozvanny I. Role of presenilins in neuronal calcium homeostasis. J Neurosci 2010, 30:8566-8580.
73. Zhang H., Webb D.J., Asmussen H., Niu S., Horwitz A.F. A GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC. J Neurosci 2005, 25:3379-3388.
74. Zhao M.G., Toyoda H., Lee Y.S., Wu L.J., Ko S.W., Zhang X.H., Jia Y., Shum F., Xu H., Li B.M., Kaang B.K., Zhuo M. Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Neuron 2005, 47:859-872.